CTRI/2021/10/037501
Completed
未知
Clinical trial to assess the efficacy of autologous platelet rich plasma (PRP) in cases of retinitis pigmentosa
GSVM Medical College0 sites39 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: H355- Hereditary retinal dystrophy
- Sponsor
- GSVM Medical College
- Enrollment
- 39
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Retinitis pigmentosa patients having\-
- •Visual acuity ranging from reading of ETDRS chart from one meter onwards to patients who will not able to read ETDRS chart but whose visual acuity will range from finger counting close to face to less than 1 meter
Exclusion Criteria
- •1\.Retinitis pigmentosa patients who will have visual acuity ranging from perception of light to hand movement.
- •2\.Diminution of vision not due to retinitis pigmentosa
- •3\. Other retinal diseases like diabetic retinopathy, hypertensive retinopathy etc
- •4\.One eyed patients
- •5\. Patients not giving consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
se of stem cells for treatment of chronic kidney diseaseChronic Kidney Disease.Hypertensive renal diseaseIRCT201509031031N17Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell10
Recruiting
Not Applicable
Clinical Study of Safety and Efficacy of Autologous Mesenchymal Stem Cells for Periodontal Tissue Regeneration TherapyPeriodontal DiseaseJPRN-jRCTb070230008Cho Yasushi22
Completed
Not Applicable
Investigator-initiated clinical trial: Autologous peripheral blood-derived CD34+ cells transplantation for bone and vascular regeneration using with MB-001 and IK-02 in patients with Fracture non-union.Fracture non-unionJPRN-UMIN000022814Foundation for Biomedical Research and Innovation at Kobe15
Terminated
Phase 1
A clinical trial of adoptive T-cell immunotherapy for patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.Metastatic nasopharyngeal carcinomaCancer - Head and neckACTRN12613000866707QIMR Berghofer Medical Research Institute18
Not yet recruiting
Not Applicable
A study to evaluate platelet rich plasma as a substance to facilitate easier removal of tumorous tissue from the intestineCTRI/2015/10/006325Andhra Medical College90